Details of the Drug
General Information of Drug (ID: DMFC564)
| Drug Name |
N-(2-bromobenzoyloxy)-4-chlorobenzamide
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
CHEMBL1253383; N-{[(2-bromophenyl)carbonyl]oxy}-4-chlorobenzamide; N-(2-bromobenzoyloxy)-4-chlorobenzamide; AC1LQE9K; CBMicro_012071; MolPort-002-189-016; ZINC1186119; SMSF0017521; STK185858; BDBM50326572; AKOS005412260; MCULE-4091237725; CB15272; [(4-chlorobenzoyl)amino] 2-bromobenzoate; BIM-0012056.P001; SR-01000230575
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 354.58 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 4.3 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


